Trials / Sponsors / Upstream Bio Inc.
Upstream Bio Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2025-07-02 |
| Active Not Recruiting | A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) Severe Asthma | Phase 2 | 2025-05-21 |
| Completed | A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma Severe Asthma | Phase 2 | 2024-02-27 |
| Completed | A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusi Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2023-12-18 |
| Completed | Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asia Healthy | Phase 1 | 2022-12-05 |
| Completed | Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asth Asthma | Phase 1 | 2022-07-08 |